EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Anthocyanin oligomer (grape skin extract) administration improves dry eye disease: A randomised, double‐blind, placebo‐controlled study

Meiqi Fan, Su Ah Kim, Young-Jin Choi, Yujiao Tang, Hyun Pil Yang, Eun-Kyung Kim iD

Clinical & Experimental Ophthalmology · 2023-03 · 51 (2) · 122-130

DOI: 10.1111/ceo.14207 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical & Experimental Ophthalmology, online erschienen am 03.02.2023. Verfasst von Meiqi Fan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Food Bioscience, College of Biomedical and Health Sciences, Konkuk University, Chungju, Republic of Korea. Hauptthemen laut MEDLINE: Vitis, Dry Eye Syndromes. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Research Foundation of Korea, Rural Development Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dry eye disease is a chronic, progressive ocular disease characterised by ocular discomfort and is one of the most common ophthalmological disorders that affects people's lives.

Methods

This study investigated the clinical efficacy of anthocyanin oligomers (grape skin extract) for the treatment of dry eye. One hundred and eight patients with dry eye were randomly divided into placebo and treatment groups, each with 54 cases. The placebo group received maltodextrin (800 mg/day) and the treatment group received anthocyanin oligomers (800 mg/day). Clinical efficacy, clinical indices, and occurrence of adverse reactions were compared between the two groups.

Results

Anthocyanin oligomers were safe and effective in mild‐to‐moderate dry eye disease, improving the tear break‐up time, intraocular pressure, ocular surface disease, and patient symptomatology.

Conclusions

The use of oral anthocyanin oligomers in the treatment of dry eye patients can enhance the therapeutic effect and improve the quality of life of patients while ensuring the safety of treatment, making this therapeutic option suitable for wider application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitisDry Eye SyndromesHumansAnthocyaninsQuality of LifeTearsDouble-Blind MethodOphthalmic Solutions

Stichwörter der Autor:innen

adverse effectsanthocyanin oligomersdry eye diseaseintraocular pressuretear film rupture time

Substanzen

AnthocyaninsOphthalmic Solutions

Autor:innen und Institutionen

  • Division of Food Bioscience, College of Biomedical and Health Sciences, Konkuk University, Chungju, Republic of Korea.
  • Department of Ophthalmology, SahmYook Medical Center, Seoul, Republic of Korea.
  • Department of Food Science and Nutrition, College of Health Science, Dong-A University, Busan, Republic of Korea.
  • Center for Silver-targeted Biomaterials, Brain Busan 21 Plus program, Dong-A University, Busan, Republic of Korea.
  • Department of Health Sciences, The Graduate School of Dong-A University, Busan, Republic of Korea.
  • Changchun University of Science and Technology, Changchun, China.

ORCID-Profile: Eun-Kyung Kim

Förderung

  • National Research Foundation of Korea
  • Rural Development Administration

Zitieren

APA

Fan, M., Kim, S. A., Choi, Y. J., Tang, Y., Yang, H. P., & Kim, E. K. (2023). Anthocyanin oligomer (grape skin extract) administration improves dry eye disease: A randomised, double‐blind, placebo‐controlled study. Clinical & Experimental Ophthalmology, 51(2), 122-130. https://doi.org/10.1111/ceo.14207

Vancouver

Fan M, Kim SA, Choi YJ, Tang Y, Yang HP, Kim EK. Anthocyanin oligomer (grape skin extract) administration improves dry eye disease: A randomised, double‐blind, placebo‐controlled study. Clinical & Experimental Ophthalmology. 2023;51(2):122-130. doi:10.1111/ceo.14207

BibTeX
@article{Fan2023,
  author = {Fan, Meiqi and Kim, Su Ah and Choi, Young-Jin and Tang, Yujiao and Yang, Hyun Pil and Kim, Eun-Kyung},
  title = {Anthocyanin oligomer (grape skin extract) administration improves dry eye disease: A randomised, double‐blind, placebo‐controlled study},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2023},
  volume = {51},
  number = {2},
  pages = {122--130},
  doi = {10.1111/ceo.14207}
}
Kostenlos starten →